Radiopharm Theranostics Ltd
RADX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001949257
No open-market purchases or sales by Radiopharm Theranostics Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesRDPTF
Q4 2025 vs. Q3 2025
How the institutions holding Radiopharm Theranostics Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 4 | 11 | +7 |
| Shares | 312.5K | 51.5M | +51.2M (+16,392.3%) |
| Value | $1.73M | $3.67M | +$1.95M (+113.0%) |
New holders (7)
Institutions that held Radiopharm Theranostics Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HSBC Holdings PLC | 191,624 | $1.01M | 0.00% |
| Stonepine Capital Management, LLC | 51,000,000 | $850.9K | 0.67% |
| Virtu Financial LLC | 14,591 | $76.0K | 0.00% |
| Jane Street Group, LLC | 14,469 | $75.5K | 0.00% |
| Marex Group plc | 10,285 | $53.7K | 0.00% |
| Strategic Wealth Partners, Ltd. | 10 | $52 | 0.00% |
| Rhumbline Advisers | 6 | $31 | 0.00% |
Sold out (0)
Institutions that held Radiopharm Theranostics Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
None.